Alphagrid

AlphaGrid helps pharma companies identify the right patients for a drug before clinical trials, improving trial success through a reusable drug-to-outcome intelligence platform.

Alphagrid is active in the health and biotech space based in US, founded in 2025.

Its activity falls under health and biotech; the profile below is assembled from public directory data.

US is where the company is located.

The company is listed at the Antler portfolio company stage of development.

Website: alpha-grid.ai